News | March 28, 2024
Caplin Group commences operations of Rs. 150 crore oncology facility
The facility will manufacture tablets, capsules, and injections for the oncology segment
The facility will manufacture tablets, capsules, and injections for the oncology segment
Cipla will be responsible for the distribution of Sanofi India's six CNS brands including Frisium
The surgeons were able to remove the entire breast while preserving the nipple through tiny hidden incisions
WINREVAIR is a breakthrough biologic for this rare, progressive disease
Hepatitis B infects over 40 million people in India
New Bioprocessing Production Center in Daejeon to supply products to customers in Asia-Pacific for development and production of biologics
Dr Madhu will oversee Apollo's hospital business and will focus on continuing to deliver the world's best clinical outcomes
The plan essentially was to separate Aster’s India and GCC businesses to unlock long-term value
Ukrainian marketing approvals for paclitaxel, oxaliplatin and irinotecan mark a significant milestone in the company’s global expansion strategy
The drug will be manufactured at the group’s formulation manufacturing facility at Ahmedabad SEZ II, India
Subscribe To Our Newsletter & Stay Updated
